Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04971772Active Not Recruiting

SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries

Role: lead

NCT07330817Not ApplicableNot Yet Recruiting

A First-In-Man Study to Assess Safety and Efficacy of Ultra High Pressure PTA Balloon ULTRAVIOLET in Treating A-V Fistula Stenosis

Role: lead

NCT04514406Terminated

APERTO CVS PMCF Study

Role: lead

NCT03745053Not ApplicableCompleted

XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization

Role: lead

NCT02710656Not ApplicableCompleted

Study Comparing Legflow Versus Bare Balloon Angioplasty for Treatment of Atherosclerotic Disease

Role: lead

All 5 trials loaded